Mitsubishi Tanabe Pharma and Hitachi have become the latest example of pharma and tech companies coming together and using artificial intelligence (AI) to improve the drug development process. Hitachi has developed AI technology for automated information search and collection, which has shortened by 70% Mitsubishi’s time spent collecting information from medical papers and other sources in designing clinical trials. (pharmaphorum)